Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials

Ashley MartonDepartment of Hematology, McGill University, Montreal, Quebec, Canada

Abbas KezouhDepartment of Epidemiology, Jewish General Hospital, Montreal, Quebec, Canada

Tina Petrogiannis-HaliotisDepartment of Pathology, Jewish General Hospital, Montreal, Quebec, Canada

Sarit AssoulineDepartment of Hematology, Jewish General Hospital, Montreal, Quebec, CanadaCorrespondence[email protected]

References

Tilly H, Dreyling M; ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19(Suppl. 2): ii67–ii69.
PubMed Web of Science ®Google Scholar
Friedberg JW. Relapsed/refractory diffuse large B-cell lymphoma. Hematology Am Soc Hematol Educ Program 2011;2011:498–505.
PubMed Web of Science ®Google Scholar
Carbone A, Gloghini A, Kwong YL, et al. Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. Ann Hematol 2014;93:1263–1277.
PubMed Web of Science ®Google Scholar
Sud R, Friedberg JW. Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab. Haematologica 2008;93:1776–1780.
PubMed Web of Science ®Google Scholar
Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006;107:265–276.
PubMed Web of Science ®Google Scholar
Baggstrom MQ, Waqar SN, Sezhiyan AK, et al. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials. J Thorac Oncol 2011;6:98–102.
PubMed Web of Science ®Google Scholar
Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728–1733.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date